Newsroom
Sorted by: Latest
-
Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Brian Poff, Executive Vice President and Chief Financial Officer, and Brad Bickham, Chief Operating Officer on an Interim Basis, will participate in the 2026 Jefferies Healthcare Services and Technology Conference, September 14 - 15, 2026, in Nashville, Tennessee. In connection with the conference, there will be a live broadcast and replay of the Company’s presentati...
-
Foot Levelers Announces First Chiropractic PracticeXcelerator®, Continuing Education and Headquarters Tour Event
ROANOKE, Va.--(BUSINESS WIRE)--Foot Levelers, today announced its first-ever ‘Founder’s Edition’ event being held at its headquarters October 24-25, 2026 featuring Dr. Ronald Oberstein and Dr. Brian Jensen. Foot Levelers, the global standard and world’s leading provider of custom stabilizing orthotics, is hosting its famous PracticeXcelerator program with the option to include Continuing Education Units and offering a rare “behind-the-scenes tour” of the Foot Levelers manufacturing facility in...
-
Medincell: Publication of the Notice of Meeting and Reminder of the Participation terms in the Combined General Meeting
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): The Annual General Meeting and Extraordinary General Meeting will be held at Medincell’s headquarters (3 rue des Frères Lumière, 34830 Jacou, France) on Wednesday, September 30, 2026, at 6:00 p.m. CEST. The notice was published in the “BALO” (French): https://www.journal-officiel.gouv.fr/telechargements/BALO/pdf/2026/0826/202608262603475.pdf The resolutions proposed for voting at the General Assembly include: Approv...
-
Medincell : Publication de la convocation et rappel des modalités de participation à l’Assemblée Générale Mixte des actionnaires
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News : Medincell (Paris:MEDCL) : L’Assemblée générale ordinaire annuelle et extraordinaire se tiendra au siège de Medincell (3 rue des Frères Lumière, 34830 Jacou) le mercredi 30 septembre 2026 à 18h00, heure de Paris. La convocation a été publiée au BALO : https://www.journal-officiel.gouv.fr/telechargements/BALO/pdf/2026/0826/202608262603475.pdf Les résolutions proposées au vote de l’Assemblée générale portent notamment sur : L’approbation des...
-
Infleqtion Leaders to Speak at Quantum World Congress 2026
LOUISVILLE, Colo.--(BUSINESS WIRE)--Infleqtion (NYSE: INFQ) (the “Company”), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced its participation at Quantum World Congress 2026, taking place Sept. 23-25, 2026, in College Park, Maryland. Infleqtion leaders will participate in multiple sessions throughout the event, including roundtable discussions focused on the advancement and application of quantum technologies. Quantum World Congress brings...
-
restor3d Launches MyFit by restor3d Digital Suite, Expanding Personalized Orthopedic Care Beyond the Operating Room
DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in personalized 3D-printed orthopedic solutions, today announced the launch of MyFit by restor3d Digital Suite, a new patient engagement ecosystem designed to provide patients with greater visibility into their personalized orthopedic journey while creating a seamless connection between patients, surgeons, and long-term clinical outcomes. MyFit by restor3d extends restor3d’s commitment to personalization beyond implant design and into the patien...
-
Ataraxis AI Launches ARC, a Large-Scale Prospective Study Linking AI Model Predictions to Real Patient Outcomes Across Oncology
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced the launch of Ataraxis ARC (the Ataraxis Real-World Clinical Outcomes Registry), a prospective, multi-site, observational study. ARC is a first-of-its-kind prospective study of AI-based tools in oncology, linking AI tool predictions with real-world short- and long-term patient outcomes.ARC will initially enroll approximately 1,000 patients acr...
-
Elavo Announces Formation as New Parent Holding Company Supporting Commercial Linen Rental and Laundry Services Businesses
MIAMI--(BUSINESS WIRE)--Elavo today announced its formation as a new parent holding company created to unify commercial linen rental and laundry services businesses....
-
Best's Review Investigates the Expanding Reach of Excess and Surplus
OLDWICK, N.J.--(BUSINESS WIRE)--In the September issue, Best’s Review explores the steady popularity of surplus lines insurers, even as admitted carriers begin to expand their capacity.Interest in the insurance industry’s surplus lines continues to grow, attracting new market entrants that are looking for flexibility as they deal with elevated forms of risk and emerging technologies. Read more in “Surplus Lines Insurers See Continued Growth as Industry Seeks Flexibility.”Best’s Review is AM Best...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 9/8/2026 Issue ¦ Barclaycard Funding PLC - Series 14 - 2 GBP 1,886,793,000 FRN due Jun 2024 ISIN Number ¦ GB009A2G4OW4 ISIN Reference ¦ 009A2G4OW Issue Nomin GBP ¦ 1886793000 Period ¦ 8/17/2026 to 9/15/2026 Payment Date 9/15/2026 Number of Days ¦ 29 Rate ¦ 4.9199 Denomination GBP ¦ 1000 ¦ 1886793000 ¦ Amount Payable per Denomination ¦ 3.91 ¦ 7375401.47 ¦ Bank of New York...